Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junctionZ.A. Wainberg, J. Randolph Hecht|British Journal of Cancer|2011Cited by 85